Rosiglitazone Regulates Anti-Inflammation and Growth Inhibition via PTEN

Peroxisome proliferator-activated receptor gamma (PPARγ) agonist has anti-inflammatory and anticancer properties. However, the mechanisms by which PPARγ agonist rosiglitazone interferes with inflammation and cancer via phosphatase and tensin homolog-(PTEN)-dependent pathway remain unclear. We found...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chiou-Feng, Young, Kung-Chia, Bai, Chyi-Huey, Yu, Bu-Chin, Ma, Ching-Ting, Chien, Yu-Chieh, Chiang, Chiu-Ling, Liao, Chao-Sheng, Lai, Hsin-Wen, Tsao, Chiung-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971553/
https://www.ncbi.nlm.nih.gov/pubmed/24757676
http://dx.doi.org/10.1155/2014/787924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971553/
https://www.ncbi.nlm.nih.gov/pubmed/24757676
http://dx.doi.org/10.1155/2014/787924

Ejemplares similares